Practice Expertise

  •  
  •  
  •  
  •  

Areas of Practice

  • Antitrust & Competition
  • Competition
  • Healthcare & Life Sciences
  • Information Technology & Telecommunications
  • Intellectual Property
  • Intellectual Property & Technology Transfer
  • Media & Communications
  • Public Law & Litigation
  • Public Procurement
  • Wettbewerbsrecht
  • View More

Profile

Lucina Herzog is a senior associate in the Regulated Markets, Competition, Technology and Intellectual Property Group. In her practice areas health & life sciences, IP and business administration law, she advises companies on regulatory, advertising and intellectual property issues. She regularly represents her clients in complex administrative proceedings before authorities and courts.

She studied Law at the University of Mannheim (First State Examination, 2018), the National Chengchi University in Taiwan and the University of Cambridge (LL.M., 2021). Before joining Walder Wyss, Lucina Herzog held her traineeship in Mannheim and Los Angeles (Second State Examination, 2020). As a trainee lawyer she worked in leading commercial law firms with a focus on competition and trademark law. She further worked as a research assistant at the University of Mannheim, specialising on German and European commercial and labour law.

Lucina Herzog advises clients in German and English. She is registered with the Zurich Bar Registry and is admitted to practice in all Switzerland.

Areas of Practice

  • Antitrust & Competition
  • Competition
  • Healthcare & Life Sciences
  • Information Technology & Telecommunications
  • Intellectual Property
  • Intellectual Property & Technology Transfer
  • Media & Communications
  • Public Law & Litigation
  • Public Procurement
  • Wettbewerbsrecht

Professional Career

Significant Accomplishments

Promotions Senior Associates

Current legal developments in the healthcare sector

Das Bundesgericht bestätigt zugunsten des deutschen Wissenschafts- und Technologieunternehmens Merck die vom Handelsgericht des Kantons Zürich ausgesprochenen, weitreichenden Verbote gegen den US-Konkurrenten MSD.

Datacolor erwirbt matchmycolor

Das IP-Team von Walder Wyss erwirkt für das deutsche Wissenschafts- und Technologieunternehmen Merck weitreichende Verbote gegen den US-Konkurrenten MSD.

Adoption of revised laws on human genetic testing





Articles


The EU AI Act: A New Layer of Regulation for AI-enabled Medical Devices
Der Umgang mit ungewöhnlich niedrigen Angeboten
Aktuelle Rechtsentwicklungen im Gesundheitswesen
La préimplication selon le droit révisé des marchés publics
Le Tribunal fédéral apporte des éclaircissements sur les exceptions quasi in-house et in-state
Bundesgericht klärt Quasi-Inhouse- und Instate-Privileg
EU-HTA-Verordnung: Regelungskern und Implikationen für die Schweiz
Aktuelle Rechtsentwicklungen im Gesundheitswesen
Aktuelle Rechtsentwicklungen im Gesundheitswesen
Überwachung der Medizinprodukte in Spitälern
Die Vorbefassung nach dem revidierten Beschaffungsrecht
The Revised Law on Human Genetic Testing
Tartlets and Trademarks - Infringement Dispute Concerning Well-Known Confectionery
Germany Terminates Convention with Switzerland on Mutual Recognition of Trade Mark Use
Warning Letters for Alleged Patent Infringement May Constitute Unfair Competition
Aktuelle Rechtsentwicklungen im Gesundheitswesen
Der Marktausgang im Konzept der Grundfreiheiten

Meet our Firms and Professionals

WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.